AETNA U S HEALTHCARE INC
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | $15.16B | $15.69B | $60.34B | $58.00B | $47.29B | $36.60B |
| Operating income | — | — | — | — | — | — |
| Net income | −$381.0M | $737.0M | $2.39B | $2.04B | $1.91B | $1.66B |
| Total assets | $55.15B | $69.15B | $53.51B | $53.40B | $49.76B | $41.39B |
| Total liabilities | $39.31B | $51.20B | $37.33B | $38.85B | $35.69B | $31.07B |
| Equity | $15.58B | $17.88B | $16.11B | $14.48B | $14.03B | $10.41B |
| EPS (diluted) | $-1.11 | $2.09 | $6.78 | $5.68 | $5.33 | $4.81 |
| Shares out. | 351.7M | 349.6M | 348.7M | 362.7M | 328.0M | 350.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- −2.5%
- Return on equity
- −2.4%
- Return on assets
- −0.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 71.3%
- Debt / equity
- 2.52×
- Book value / share
- $44.30
- Revenue growth (YoY)
- −3.4%
- Net income growth (YoY)
- −151.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Accruals / assets
- 0.2%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 1 good- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Other material eventDec 4, 2018
- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 28, 2018
- Other material eventNov 26, 2018
- Results of operationsOct 30, 2018
- Other material eventOct 11, 2018
- Other material eventOct 10, 2018
- Other material eventSep 27, 2018
- Results of operationsAug 2, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2019
- 15-12BFORM 15-12BDec 10, 2018
- 8-KFORM 8-KDec 4, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018
- S-8 POSFORM S-8 POSNov 29, 2018